You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
It's also a pretty big pill. Metformin is not diminutive like a baby aspirin. You need a big glug of water to wash it down. In fact, some people who should be taking it don't take it because it's too hard for them to swallow.
That's why an announcement from Massachusetts-based Generex Biotechnology Corp. is happy news: Data from an ongoing clinical trial of its proprietary MetControlTM chewing gum show that a chewable form of metformin is therapeutically equivalent to the tablet form and is absorbed and metabolized at the same rate.
In other words, you may soon be able to chew your metformin the same way you chew a stick of sugarless gum and derive the same benefits you get now from tablets.
Twenty-four subjects are involved in the study at West Houston Clinical Research Services in Houston, Texas, intended to see if MetControl is "bioequivalent" to traditional immediate-release metformin tablets.
So far, so good, with no serious adverse effects reported.
Once Generex confirms the study's data, it will seek regulatory approval for MetControl as a generic metformin product. Because metformin is not a new or unproven drug, the company expects the chewing gum to travel a much shorter path to the market than a so-called "new chemical entity" drug.
Even so, Generex has not said when MetControl might get into the hands of type 2s.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.